Aspergillus flavus is a major fungal pathogen of vegetation and an opportunistic pathogen of people. In addition to the direct affect of an infection, it produces immunosuppressive and carcinogenic aflatoxins. The early detection of A. flavus is due to this fact essential to diagnose and monitor fungal an infection, to stop aflatoxin contamination of meals and feed, and for efficient antifungal remedy. Aspergillus-specific monoclonal antibodies (mAbs) are promising as diagnostic and therapeutic reagents for the monitoring and therapy of Aspergillus infections, respectively.
However, A. flavus has a posh cell wall composition and dynamic morphology, hindering the discovery of mAbs with well-characterized targets. Here we describe the technology and detailed characterization of mAb5.52 (IgG2aκ) and mAb17.15 (IgG1κ), which bind particularly to the extremely immunogenic cell wall antigen A. flavus mannoprotein 1 (Aflmp1). Both mAbs have been generated utilizing hybridoma know-how following the immunization of mice with a recombinant truncated model of Aflmp1 (ExD, together with the homologous CR4 area) produced in micro organism. We present that mAb5.52 and mAb17.15 bind particularly to A. flavus and A. parasiticus cell wall fragments (CWFs), with no cross-reaction to CWFs from different fungal pathogens.
Immunofluorescence microscopy revealed that each mAbs bind to the floor of Aspergillus hyphae and that mAb17.15 additionally binds to spores. The epitope for each mAbs is localized inside the CR4 area of the Aflmp1 protein. These Aspergillus-specific mAbs could also be helpful for the early detection of fungal an infection in meals/feed crops, for serodiagnosis in sufferers with invasive aspergillosis attributable to A. flavus an infection and for the improvement of antibody-expressing disease-resistant crops. The epidermal development issue receptor (EGFR) is a tyrosine kinase receptor that performs an necessary function in regular epidermal cell physiology.
EGFR is overexpressed in most cancers cells and has a quantity of mutations that implicate tumor malignancy, improvement, and poor affected person prognosis; thus, EGFR is a pretty goal for most cancers remedy. At current, anti-EGFR monoclonal antibodies (mAbs) have been authorized and are used for treating sufferers with a range of EGFR-expressing cancers.
Tubulointerstitial nephritis in antineutrophil cytoplasmic antibody-associated vasculitis with monoclonal gammopathy
Isolated tubulointerstitial nephritis (TIN) with out glomerular crescent formation is a uncommon manifestation of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Some sufferers with monoclonal gammopathy of undetermined significance current with renal issues as a result of serum monoclonal protein. Here, we current a case of TIN presumably attributable to AAV with monoclonal gammopathy. Laboratory knowledge revealed acute kidney damage, elevated C-reactive protein (CRP) and ANCA titers, and elevated tubular damage markers. Renal biopsy revealed TIN with no obvious glomerular lesion. The findings of peritubular capillaritis and tubulitis indicated that AAV had contributed to the improvement of TIN.
However, in situ hybridization for free mild chains revealed kappa mild chain restriction, indicating that the involvement of monoclonal gammopathy in the pathogenesis of TIN stays potential. The affected person additionally developed ophthalmic neuropathy, in all probability attributable to AAV. Oral prednisone (0.6 mg/kg/day) administration improved each the ocular signs and the laboratory parameters. Our case demonstrated that the concurrence of AAV and monoclonal gammopathy might pose a diagnostic dilemma in distinguishing the trigger of TIN. Besides, some studies recommend an affiliation between AAV and monoclonal gammopathy, though direct proof is missing. Further analysis is required to determine this affiliation.
CD44 capabilities as a major hyaluronan receptor on most cell varieties, with roles in cell adhesion, migration, proliferation, differentiation, and survival. The CD44 gene includes 20 exons, with different splicing producing many various isoforms. CD44 variant isoforms exhibit tissue-specific expression patterns and have been studied as therapeutic targets for a number of cancers; due to this fact, anti-CD44 monoclonal antibodies (mAbs) are helpful for investigating CD44 expression in varied cancers.

Isolation and characterization of porcine monoclonal antibodies revealed two distinct serotype-independent epitopes on VP2 of foot-and-mouth illness virus
Pigs are prone to foot-and-mouth illness virus (FMDV), and the humoral immune response performs a vital function in safety in opposition to FMDV an infection. However, little info is obtainable about FMDV-specific mAbs derived from single B cells of pigs. This research aimed to find out the antigenic options of FMDV which are acknowledged by antibodies from pigs. Therefore, a panel of pig-derived mAbs in opposition to FMDV have been developed utilizing fluorescence-based single B cell antibody know-how. Western blotting revealed that three of the antibodies acknowledged conserved antigen epitopes on capsid protein VP2, and exhibited broad reactivity in opposition to each FMDV serotypes A and O.
Recombinant Rat Angiotensinogen (Agt) |
MBS950608-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1270 |
Recombinant Angiotensinogen (AGT) |
MBS2010533-001mg |
MyBiosource |
0.01mg |
EUR 180 |
Recombinant Angiotensinogen (AGT) |
MBS2010533-005mg |
MyBiosource |
0.05mg |
EUR 330 |
Recombinant Angiotensinogen (AGT) |
MBS2010533-01mg |
MyBiosource |
0.1mg |
EUR 500 |
Recombinant Angiotensinogen (AGT) |
MBS2010533-02mg |
MyBiosource |
0.2mg |
EUR 615 |
Recombinant Angiotensinogen (AGT) |
MBS2010533-05mg |
MyBiosource |
0.5mg |
EUR 1170 |
Recombinant Angiotensinogen (AGT) |
MBS2010720-001mg |
MyBiosource |
0.01mg |
EUR 180 |
Recombinant Angiotensinogen (AGT) |
MBS2010720-005mg |
MyBiosource |
0.05mg |
EUR 330 |
Recombinant Angiotensinogen (AGT) |
MBS2010720-01mg |
MyBiosource |
0.1mg |
EUR 500 |
Recombinant Angiotensinogen (AGT) |
MBS2010720-02mg |
MyBiosource |
0.2mg |
EUR 615 |
Recombinant Angiotensinogen (AGT) |
MBS2010720-05mg |
MyBiosource |
0.5mg |
EUR 1170 |
Recombinant Angiotensinogen (AGT) |
MBS2009330-001mg |
MyBiosource |
0.01mg |
EUR 155 |
Recombinant Angiotensinogen (AGT) |
MBS2009330-005mg |
MyBiosource |
0.05mg |
EUR 260 |
Recombinant Angiotensinogen (AGT) |
MBS2009330-01mg |
MyBiosource |
0.1mg |
EUR 375 |
Recombinant Angiotensinogen (AGT) |
MBS2009330-02mg |
MyBiosource |
0.2mg |
EUR 460 |
Recombinant Angiotensinogen (AGT) |
MBS2009330-05mg |
MyBiosource |
0.5mg |
EUR 860 |
Recombinant Angiotensinogen (AGT) |
MBS2011101-001mg |
MyBiosource |
0.01mg |
EUR 155 |
Recombinant Angiotensinogen (AGT) |
MBS2011101-005mg |
MyBiosource |
0.05mg |
EUR 260 |
Recombinant Angiotensinogen (AGT) |
MBS2011101-01mg |
MyBiosource |
0.1mg |
EUR 375 |
Recombinant Angiotensinogen (AGT) |
MBS2011101-02mg |
MyBiosource |
0.2mg |
EUR 460 |
Recombinant Angiotensinogen (AGT) |
MBS2011101-05mg |
MyBiosource |
0.5mg |
EUR 860 |
Recombinant Angiotensinogen (AGT) |
RPA797Hu01 |
Cloud-Clone |
10ug |
EUR 194 |
Recombinant Angiotensinogen (AGT) |
4-RPA797Hu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 5 mg
- 10ug
- 50ug
- 100 ug
- 200 ug
- 500 ug
- 1 mg
|
|
Description: Recombinant Human Angiotensinogen expressed in: E.coli |
Recombinant Angiotensinogen (AGT) |
RPA797Hu02 |
Cloud-Clone |
10ug |
EUR 194 |
Recombinant Angiotensinogen (AGT) |
4-RPA797Hu02 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 5 mg
- 10ug
- 50ug
- 100 ug
- 200 ug
- 500 ug
- 1 mg
|
|
Description: Recombinant Human Angiotensinogen expressed in: E.coli |
Recombinant Angiotensinogen (AGT) |
RPA797Mu01 |
Cloud-Clone |
10ug |
EUR 140 |
Recombinant Angiotensinogen (AGT) |
4-RPA797Mu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 5 mg
- 10ug
- 50ug
- 100 ug
- 200 ug
- 500 ug
- 1 mg
|
|
Description: Recombinant Mouse Angiotensinogen expressed in: E.coli |
Recombinant Angiotensinogen (AGT) |
RPA797Ra01 |
Cloud-Clone |
10ug |
EUR 140 |
Recombinant Angiotensinogen (AGT) |
4-RPA797Ra01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 5 mg
- 10ug
- 50ug
- 100 ug
- 200 ug
- 500 ug
- 1 mg
|
|
Description: Recombinant Rat Angiotensinogen expressed in: E.coli |
Recombinant Rat Angiotensinogen/AGT protein (His tag) |
MBS2571490-002mg |
MyBiosource |
0.02mg |
EUR 305 |
Recombinant Rat Angiotensinogen/AGT protein (His tag) |
MBS2571490-01mg |
MyBiosource |
0.1mg |
EUR 490 |
Recombinant Rat Angiotensinogen/AGT protein (His tag) |
MBS2571490-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2185 |
Recombinant Rat Angiotensinogen/AGT protein (His tag) |
PDMR100022-100ug |
Elabscience Biotech |
100ug |
EUR 499 |
|
Description: Rat |
Recombinant Rat Angiotensinogen/AGT protein (His tag) |
PDMR100022-20ug |
Elabscience Biotech |
20ug |
EUR 299 |
|
Description: Rat |
Recombinant Human Angiotensinogen |
MBS954800-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1320 |
Recombinant Human Angiotensinogen |
MBS954800-002mgMammalianCell |
MyBiosource |
0.02mg(Mammalian-Cell) |
EUR 1585 |
Recombinant Human Angiotensinogen |
MBS954800-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1115 |
Recombinant Human Angiotensinogen |
MBS954800-01mgBaculovirus |
MyBiosource |
0.1mg(Baculovirus) |
EUR 1900 |
Recombinant Human Angiotensinogen |
MBS954800-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1270 |
Recombinant Horse Angiotensinogen (AGT) |
MBS718491-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 875 |
Recombinant Horse Angiotensinogen (AGT) |
MBS718491-005mgEColi |
MyBiosource |
0.05mg(E-Coli) |
EUR 490 |
Recombinant Horse Angiotensinogen (AGT) |
MBS718491-005mgYeast |
MyBiosource |
0.05mg(Yeast) |
EUR 695 |
Recombinant Horse Angiotensinogen (AGT) |
MBS718491-02mgEColi |
MyBiosource |
0.2mg(E-Coli) |
EUR 645 |
Recombinant Horse Angiotensinogen (AGT) |
MBS718491-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 700 |
Recombinant Sheep Angiotensinogen (AGT) |
MBS948831-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1320 |
Recombinant Sheep Angiotensinogen (AGT) |
MBS948831-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1010 |
Recombinant Sheep Angiotensinogen (AGT) |
MBS948831-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1115 |
Recombinant Sheep Angiotensinogen (AGT) |
MBS948831-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1180 |
Recombinant Sheep Angiotensinogen (AGT) |
MBS948831-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1270 |
Recombinant Mouse Angiotensinogen (Agt) |
MBS949091-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1320 |
Recombinant Mouse Angiotensinogen (Agt) |
MBS949091-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1010 |
Recombinant Mouse Angiotensinogen (Agt) |
MBS949091-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1115 |
Recombinant Mouse Angiotensinogen (Agt) |
MBS949091-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1180 |
Recombinant Mouse Angiotensinogen (Agt) |
MBS949091-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1270 |
Angiotensinogen Recombinant Rabbit mAb |
BS48837 |
Bioworld Biotech |
50 ul |
EUR 398 |
|
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt. |
Angiotensinogen Recombinant Rabbit mAb |
BS49196 |
Bioworld Biotech |
50 ul |
EUR 398 |
|
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt. |
Angiotensinogen Recombinant Rabbit mAb |
BS45966 |
Bioworld Biotech |
50 ul |
EUR 398 |
|
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt. |
Angiotensinogen Recombinant Rabbit mAb |
BS47031 |
Bioworld Biotech |
50 ul |
EUR 398 |
|
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt. |
Angiotensinogen Recombinant Rabbit mAb |
BS47858 |
Bioworld Biotech |
50 ul |
EUR 398 |
|
Description: Store at -20°C. Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt. |
Recombinant Bovine Angiotensinogen (AGT) |
MBS953438-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 935 |
Recombinant Bovine Angiotensinogen (AGT) |
MBS953438-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 485 |
Recombinant Bovine Angiotensinogen (AGT) |
MBS953438-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 705 |
Recombinant Bovine Angiotensinogen (AGT) |
MBS953438-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 575 |
Recombinant Bovine Angiotensinogen (AGT) |
MBS953438-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 805 |
Recombinant Chicken Angiotensinogen (AGT) |
MBS964225-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 875 |
Recombinant Chicken Angiotensinogen (AGT) |
MBS964225-005mgEColi |
MyBiosource |
0.05mg(E-Coli) |
EUR 485 |
Recombinant Chicken Angiotensinogen (AGT) |
MBS964225-005mgYeast |
MyBiosource |
0.05mg(Yeast) |
EUR 705 |
Recombinant Chicken Angiotensinogen (AGT) |
MBS964225-02mgEColi |
MyBiosource |
0.2mg(E-Coli) |
EUR 635 |
Recombinant Chicken Angiotensinogen (AGT) |
MBS964225-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 700 |
Recombinant Human Angiotensinogen Protein |
MBS9141858-002mg |
MyBiosource |
0.02mg |
EUR 195 |
Recombinant Human Angiotensinogen Protein |
MBS9141858-005mg |
MyBiosource |
0.05mg |
EUR 280 |
Recombinant Human Angiotensinogen Protein |
MBS9141858-01mg |
MyBiosource |
0.1mg |
EUR 385 |
Recombinant Human Angiotensinogen Protein |
MBS9141858-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1555 |
Recombinant Human Angiotensinogen (AGT), partial |
CSB-EP001463HU1 |
Cusabio |
508 mg |
Ask for price |
Recombinant Human Angiotensinogen (AGT), partial |
CSB-EP001463HU1-20ug |
Cusabio |
20ug |
Ask for price |
|
Description: 44-427aa |
Recombinant Human Angiotensinogen(AGT),partial |
AP76501 |
SAB |
1mg |
EUR 1978 |
|
Recombinant Human Angiotensinogen (AGT), partial |
MBS7110813-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 255 |
Recombinant Human Angiotensinogen (AGT), partial |
MBS7110813-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 405 |
Recombinant Human Angiotensinogen (AGT), partial |
MBS7110813-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 1425 |
Recombinant Human Angiotensinogen (AGT), partial |
MBS7110813-5x1mgEColi |
MyBiosource |
5x1mg(E-Coli) |
EUR 6215 |
Recombinant Human Angiotensinogen/AGT Protein |
RP01021 |
Abclonal |
5 μg |
EUR 209.01 |
|
Recombinant Mouse Angiotensinogen/AGT Protein |
RP01621 |
Abclonal |
100μg |
EUR 41.8 |
|
Recombinant Human Angiotensinogen, His-tagged |
AGT-2182H |
Creative BioMart |
10ug |
EUR 238.4 |
|
Description: Avoid repeated freeze/thaw cycles. Store at 2-8-deg-C for one month. Aliquot and store at -80-deg-C for 12 months. |
Angiotensinogen (1-14) , Rat |
5-00699 |
CHI Scientific |
4 x 5mg |
EUR 319.41 |
Description: Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Tyr-Tyr-Ser |
Angiotensinogen (1-14) (Rat) |
MBS8246103-10mg |
MyBiosource |
10mg |
EUR 845 |
Angiotensinogen (1-14) (Rat) |
MBS8246103-1mg |
MyBiosource |
1mg |
EUR 295 |
Angiotensinogen (1-14) (Rat) |
MBS8246103-5mg |
MyBiosource |
5mg |
EUR 595 |
Angiotensinogen (1-14) (Rat) |
MBS8246103-5x10mg |
MyBiosource |
5x10mg |
EUR 3710 |
Recombinant Pan troglodytes Angiotensinogen (AGT) |
MBS1474316-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1320 |
Recombinant Pan troglodytes Angiotensinogen (AGT) |
MBS1474316-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1010 |
Recombinant Pan troglodytes Angiotensinogen (AGT) |
MBS1474316-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1115 |
Recombinant Pan troglodytes Angiotensinogen (AGT) |
MBS1474316-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1180 |
Recombinant Pan troglodytes Angiotensinogen (AGT) |
MBS1474316-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1270 |
Angiotensinogen (AGT) (NM_000029) Human Recombinant Protein |
E45H40174M5 |
EnoGene |
20 ug |
EUR 785.42 |
Rat Angiotensinogen ELISA |
MBS495577-5x96Tests |
MyBiosource |
5x96Tests |
EUR 3945 |
Rat Angiotensinogen ELISA |
MBS495577-96Tests |
MyBiosource |
96Tests |
EUR 855 |
Angiotensinogen Protein, Mouse, Recombinant (His Tag) |
E45M52669M2-100 |
EnoGene |
100 ug |
EUR 1046.77 |
Angiotensinogen Protein, Human, Recombinant (His Tag) |
E45H51255M2-50 |
EnoGene |
50 ug |
EUR 870.73 |
Recombinant Human Angiotensinogen Protein, His Tag |
E40KMP1417 |
EnoGene |
20ug |
EUR 495 |
Angiotensinogen Protein, Human, Recombinant (His Tag) |
MBS8120618-005mg |
MyBiosource |
0.05mg |
EUR 340 |
Angiotensinogen Protein, Human, Recombinant (His Tag) |
MBS8120618-5x005mg |
MyBiosource |
5x0.05mg |
EUR 1380 |
Angiotensinogen Protein, Mouse, Recombinant (His Tag) |
MBS8122693-01mg |
MyBiosource |
0.1mg |
EUR 395 |
Angiotensinogen Protein, Mouse, Recombinant (His Tag) |
MBS8122693-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1635 |
Recombinant Callithrix jacchus Angiotensinogen (AGT) |
MBS1361828-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1320 |
Recombinant Callithrix jacchus Angiotensinogen (AGT) |
MBS1361828-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1010 |
Recombinant Callithrix jacchus Angiotensinogen (AGT) |
MBS1361828-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1115 |
Recombinant Callithrix jacchus Angiotensinogen (AGT) |
MBS1361828-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1180 |
Recombinant Callithrix jacchus Angiotensinogen (AGT) |
MBS1361828-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1270 |
Recombinant Human Angiotensinogen protein (C-6His) |
CD02340-10ug |
Jiaxing Korain Biotech Ltd (BT Labs) |
10ug |
EUR 353 |
|
Description: Recombinant Human Serine Protease Inhibitor-clade A8 is produced by our Mammalian expression system and the target gene encoding Asp34-Ala485 is expressed with a 6His tag at the C-terminus. |
Recombinant Human Angiotensinogen protein (C-6His) |
CD02340-50ug |
Jiaxing Korain Biotech Ltd (BT Labs) |
50ug |
EUR 1035 |
|
Description: Recombinant Human Serine Protease Inhibitor-clade A8 is produced by our Mammalian expression system and the target gene encoding Asp34-Ala485 is expressed with a 6His tag at the C-terminus. |
Recombinant Human Angiotensinogen, His-GST-tagged |
AGT-2183H |
Creative BioMart |
10ug |
EUR 238.4 |
|
Description: Avoid repeated freeze/thaw cycles. Store at 2-8-deg-C for one month. Aliquot and store at -80-deg-C for 12 months. |
Recombinant Human Angiotensinogen/AGT Protein (His Tag) |
PKSH032069-10ug |
Elabscience Biotech |
10ug |
EUR 223 |
|
Description: Human |
Recombinant Human Angiotensinogen/AGT Protein (His Tag) |
PKSH032069-50ug |
Elabscience Biotech |
50ug |
EUR 593 |
|
Description: Human |
Rat Angiotensinogen CLIA Kit |
MBS8426568-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Rat angiotensinogen ELISA kit |
55R-2262 |
Fitzgerald |
1 kit |
EUR 1427 |
Description: Rat angiotensinogen ELISA kit for use in research |
Rat Angiotensinogen ELISA kit |
E01A8964 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Rat Angiotensinogen ELISA kit |
E02A0497-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rat Angiotensinogen in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Angiotensinogen ELISA kit |
E02A0497-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rat Angiotensinogen in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Angiotensinogen ELISA kit |
E02A0497-48wellsplate |
BlueGene |
48 wells plate |
EUR 280 |
Rat Angiotensinogen ELISA kit |
E02A0497-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rat Angiotensinogen in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Angiotensinogen ELISA kit |
E02A0497-96wellsplate |
BlueGene |
96 wells plate |
EUR 405 |
Rat Angiotensinogen ELISA Kit |
MBS039372-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Rat Angiotensinogen ELISA Kit |
MBS039372-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Rat Angiotensinogen ELISA Kit |
MBS039372-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Rat Angiotensinogen ELISA Kit |
MBS039372-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Rat Angiotensinogen ELISA Kit |
IRTAGTKT |
Innovative research |
each |
EUR 624 |
|
Description: Rat Angiotensinogen ELISA Kit |
Rat Angiotensinogen ELISA Kit |
MBS2881360-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 4080 |
Rat Angiotensinogen ELISA Kit |
MBS2881360-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 390 |
Rat Angiotensinogen ELISA Kit |
MBS2881360-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2220 |
Rat Angiotensinogen ELISA Kit |
MBS2881360-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 520 |
Rat Angiotensinogen ELISA Kit |
MBS728265-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 5685 |
Rat Angiotensinogen ELISA Kit |
MBS728265-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 485 |
Rat Angiotensinogen ELISA Kit |
MBS728265-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3020 |
Rat Angiotensinogen ELISA Kit |
MBS728265-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 690 |
Rat Angiotensinogen ELISA Kit |
MBS762162-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3900 |
Rat Angiotensinogen ELISA Kit |
MBS762162-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 340 |
Rat Angiotensinogen ELISA Kit |
MBS762162-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2045 |
Rat Angiotensinogen ELISA Kit |
MBS762162-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 455 |
Recombinant Gorilla gorilla gorilla Angiotensinogen (AGT) |
MBS1450817-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1320 |
Recombinant Gorilla gorilla gorilla Angiotensinogen (AGT) |
MBS1450817-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 1010 |
Recombinant Gorilla gorilla gorilla Angiotensinogen (AGT) |
MBS1450817-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 1115 |
Recombinant Gorilla gorilla gorilla Angiotensinogen (AGT) |
MBS1450817-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 1180 |
Recombinant Gorilla gorilla gorilla Angiotensinogen (AGT) |
MBS1450817-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1270 |
Recombinant Human Angiotensinogen/Serpin A8/AGT (C-6His) |
CB56-10ug |
Novoprotein |
10ug |
EUR 242.4 |
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human Angiotensinogen/Serpin A8/AGT (C-6His) |
CB56-1mg |
Novoprotein |
1mg |
EUR 2983.2 |
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human Angiotensinogen/Serpin A8/AGT (C-6His) |
CB56-500ug |
Novoprotein |
500ug |
EUR 2106 |
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human Angiotensinogen/Serpin A8/AGT (C-6His) |
CB56-50ug |
Novoprotein |
50ug |
EUR 595.2 |
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human Angiotensinogen/Serpin A8/AGT (C-6His) |
AP75516 |
SAB |
1mg |
EUR 3489 |
|
Rat Angiotensinogen (AGT) Protein |
abx065353-100g |
Abbexa |
100 µg |
EUR 337.5 |
An alanine-substitution scanning assay and sequence conservation evaluation elucidated that these porcine mAbs acknowledged two conserved epitopes on VP2: a linear epitope in the N terminus and a conformational epitope involving residues Ok63, H65, L66, F67, D68 and L81 on two β-sheets (B-sheet and C-sheet) that trusted the integrity of VP2. Random parings of heavy and mild chains of the IgGs confirmed that the heavy chain is predominantly concerned in binding to antigen. The mild chain of porcine IgG contributes to the binding affinity towards an antigen and might operate as a help platform for antibody stability. In abstract, this research is the first to disclose the conserved antigenic profile of FMDV acknowledged by porcine B cells and offers a novel technique for analysing the antibody response in opposition to FMDV in its pure hosts (i.e. pigs) at the clonal stage.